サワイグループホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/09/05 | 4,030 | 4,050 | 4,005 | 4,010 | -75 | -1.8% | 103,800 |
| 2022/09/02 | 4,060 | 4,095 | 3,990 | 4,085 | +45 | +1.1% | 199,300 |
| 2022/09/01 | 4,085 | 4,140 | 4,035 | 4,040 | -75 | -1.8% | 157,900 |
| 2022/08/31 | 4,120 | 4,140 | 4,065 | 4,115 | -95 | -2.3% | 244,000 |
| 2022/08/30 | 4,175 | 4,240 | 4,150 | 4,210 | +60 | +1.4% | 587,500 |
| 2022/08/29 | 4,105 | 4,175 | 4,090 | 4,150 | -50 | -1.2% | 138,400 |
| 2022/08/26 | 4,150 | 4,215 | 4,145 | 4,200 | +50 | +1.2% | 131,800 |
| 2022/08/25 | 4,150 | 4,195 | 4,140 | 4,150 | -35 | -0.8% | 120,200 |
| 2022/08/24 | 4,225 | 4,240 | 4,165 | 4,185 | -55 | -1.3% | 101,400 |
| 2022/08/23 | 4,250 | 4,260 | 4,205 | 4,240 | -30 | -0.7% | 111,600 |
| 2022/08/22 | 4,230 | 4,270 | 4,195 | 4,270 | +35 | +0.8% | 94,000 |
| 2022/08/19 | 4,245 | 4,260 | 4,210 | 4,235 | +15 | +0.4% | 145,800 |
| 2022/08/18 | 4,210 | 4,240 | 4,165 | 4,220 | +30 | +0.7% | 118,500 |
| 2022/08/17 | 4,275 | 4,280 | 4,165 | 4,190 | -15 | -0.4% | 164,100 |
| 2022/08/16 | 4,295 | 4,295 | 4,175 | 4,205 | -105 | -2.4% | 173,700 |
| 2022/08/15 | 4,215 | 4,320 | 4,210 | 4,310 | +110 | +2.6% | 134,400 |
| 2022/08/12 | 4,160 | 4,285 | 4,150 | 4,200 | -115 | -2.7% | 314,400 |
| 2022/08/10 | 4,290 | 4,340 | 4,230 | 4,315 | +5 | +0.1% | 224,300 |
| 2022/08/09 | 4,350 | 4,375 | 4,300 | 4,310 | -55 | -1.3% | 139,600 |
| 2022/08/08 | 4,370 | 4,400 | 4,350 | 4,365 | ±0 | ±0% | 109,500 |
| 2022/08/05 | 4,315 | 4,370 | 4,310 | 4,365 | +5 | +0.1% | 167,600 |
| 2022/08/04 | 4,350 | 4,375 | 4,325 | 4,360 | +50 | +1.2% | 131,600 |
| 2022/08/03 | 4,290 | 4,330 | 4,265 | 4,310 | +45 | +1.1% | 159,700 |
| 2022/08/02 | 4,350 | 4,370 | 4,240 | 4,265 | -130 | -3% | 155,100 |
| 2022/08/01 | 4,330 | 4,400 | 4,275 | 4,395 | +85 | +2% | 89,000 |
| 2022/07/29 | 4,365 | 4,400 | 4,300 | 4,310 | -105 | -2.4% | 140,200 |
| 2022/07/28 | 4,405 | 4,415 | 4,350 | 4,415 | +5 | +0.1% | 117,500 |
| 2022/07/27 | 4,405 | 4,430 | 4,375 | 4,410 | +5 | +0.1% | 129,400 |
| 2022/07/26 | 4,460 | 4,480 | 4,395 | 4,405 | -65 | -1.5% | 84,800 |
| 2022/07/25 | 4,440 | 4,480 | 4,425 | 4,470 | +10 | +0.2% | 82,100 |
| 2022/07/22 | 4,455 | 4,475 | 4,420 | 4,460 | ±0 | ±0% | 121,000 |
| 2022/07/21 | 4,330 | 4,470 | 4,330 | 4,460 | +60 | +1.4% | 132,100 |
| 2022/07/20 | 4,405 | 4,410 | 4,360 | 4,400 | +95 | +2.2% | 126,300 |
| 2022/07/19 | 4,315 | 4,330 | 4,275 | 4,305 | -10 | -0.2% | 117,600 |
| 2022/07/15 | 4,385 | 4,385 | 4,305 | 4,315 | -40 | -0.9% | 130,900 |
| 2022/07/14 | 4,320 | 4,360 | 4,305 | 4,355 | +35 | +0.8% | 113,400 |
| 2022/07/13 | 4,290 | 4,370 | 4,280 | 4,320 | +20 | +0.5% | 132,500 |
| 2022/07/12 | 4,280 | 4,320 | 4,255 | 4,300 | -30 | -0.7% | 130,700 |
| 2022/07/11 | 4,290 | 4,345 | 4,280 | 4,330 | +80 | +1.9% | 138,700 |
| 2022/07/08 | 4,240 | 4,270 | 4,160 | 4,250 | +40 | +1% | 194,200 |
| 2022/07/07 | 4,210 | 4,240 | 4,185 | 4,210 | +25 | +0.6% | 96,600 |
| 2022/07/06 | 4,145 | 4,200 | 4,140 | 4,185 | +15 | +0.4% | 79,400 |
| 2022/07/05 | 4,140 | 4,180 | 4,120 | 4,170 | ±0 | ±0% | 139,800 |
| 2022/07/04 | 4,175 | 4,180 | 4,145 | 4,170 | +45 | +1.1% | 74,500 |
| 2022/07/01 | 4,115 | 4,185 | 4,095 | 4,125 | +10 | +0.2% | 148,500 |
| 2022/06/30 | 4,160 | 4,195 | 4,100 | 4,115 | +10 | +0.2% | 157,400 |
| 2022/06/29 | 4,095 | 4,120 | 4,060 | 4,105 | -40 | -1% | 221,800 |
| 2022/06/28 | 4,070 | 4,150 | 4,065 | 4,145 | +20 | +0.5% | 160,200 |
| 2022/06/27 | 4,190 | 4,190 | 4,090 | 4,125 | -70 | -1.7% | 164,700 |
| 2022/06/24 | 4,285 | 4,285 | 4,140 | 4,195 | -85 | -2% | 200,000 |
651～
700
件表示中 / 1000件
類似銘柄と比較する
現在ご覧いただいている「サワイＧＨＤ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| サワイＧＨＤ | 203,300円 | +4.0% | +25.4% | 2.61% | 8.89倍 | 1.17倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| ペプチド | 201,800円 | +5.0% | +1.5% | 0.00% | 17.33倍 | 4.61倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| 日本新薬 | 373,500円 | +7.9% | +8.9% | 3.32% | 7.99倍 | 1.07倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 科研薬 | 407,200円 | +30.5% | +111.0% | 4.67% | 11.48倍 | 1.00倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| キッセイ薬 | 379,500円 | +14.5% | -2.3% | 2.37% | 13.88倍 | 0.74倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
市場注目の銘柄
チャート関連のコラム
